August 14, 2025

Greater Variety of Flavonoids Tied to Lower Chronic Disease

Higher diversity and quantity of dietary flavonoid intake were each linked to reduced risks of mortality and major chronic diseases in a large population-based study.

Conexiant

August 11, 2025

FDA OKs Bioequivalent Iron Sucrose for CKD Anemia

The FDA has approved a bioequivalent iron sucrose injection for treating iron deficiency anemia in patients with chronic kidney disease.

Conexiant

August 07, 2025

Every 1,000 Steps May Slash Heart Risk 17%

Each additional 1,000 daily steps a day may be associated with a reduction in major adverse cardiovascular events among patients with hypertension, with benefits evident at step counts well below 10,000 steps per day.

Conexiant

August 07, 2025

Delayed Hypertension Diagnoses Raise 5-Year Cardiovascular Risk

Analysis of electronic health records reveals that delays in clinical hypertension diagnosis persist despite frequent outpatient visits and are linked to increased cardiovascular event rates.

Conexiant

August 01, 2025

Consistent or Increasing Physical Activity Across Adulthood Linked to Lower Mortality

This large meta-analysis on physical activity patterns and mortality—encompassing 85 prospective cohort studies—shows that consistent or increasing physical activity during adulthood is associated with lower all-cause and cardiovascular mortality risk.

Conexiant

July 30, 2025

Mortality Among Surgeons in the United States 

National mortality data reveal that surgeons face higher death rates than non-surgeon physicians, with cancer and external causes contributing prominently.

Conexiant

July 30, 2025

Women With Diabetes Face Higher CMD Risk

A detailed look beneath the surface of asymptomatic type 2 diabetes (T2D) reveals a telling difference between men and women, one that begins at the level of the heart’s smallest vessels.

Conexiant

July 28, 2025

Top 10 States to Practice Cardiology

A state-by-state guide for cardiologists seeking the most rewarding places to build their careers, blending compensation, lifestyle, and growth potential.

Conexiant

July 21, 2025

Remdesivir Not Tied to Cardiac Risk

In a meta-analysis of 4566 patients with COVID-19, researchers found no statistically significant increase in cardiac adverse events associated with remdesivir treatment and concluded that the drug does not raise heart-related safety concerns.

Conexiant